학술논문
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Document Type
Article
Author
Fizazi, Karim ; Foulon, Stéphanie; Carles, Joan; Roubaud, Guilhem; McDermott, Ray; Fléchon, Aude; Tombal, Bertrand; Supiot, Stéphane; Berthold, Dominik; Ronchin, Philippe; Kacso, Gabriel; Gravis, Gwenaëlle; Calabro, Fabio; Berdah, Jean-François; Hasbini, Ali; Silva, Marlon; Thiery-Vuillemin, Antoine; Latorzeff, Igor; Mourey, Loïc; Laguerre, Brigitte; Abadie-Lacourtoisie, Sophie; Martin, Etienne; El Kouri, Claude; Escande, Anne; Rosello, Alvar; Magne, Nicolas; Schlurmann, Friederike; Priou, Frank; Chand-Fouche, Marie-Eve; Freixa, Salvador Villà; Jamaluddin, Muhammad; Rieger, Isabelle; Bossi, Alberto
Source
In The Lancet 30 April-6 May 2022 399(10336):1695-1707
Subject
Language
ISSN
0140-6736